Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-28

Clinical Trial Update: Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases [NA]

View source ↗

Summary

The clinical trial NCT02049736 evaluating telbivudine for renal function and proteinuria in chronic hepatitis B patients with chronic kidney disease has been wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telbivudine (telbivudine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Chronic Hepatitis B | NA | Status: WITHDRAWN